SARS-CoV-2, the COVID-19 virus, caused significant neuron damage and inflammation within a week of infection in rhesus macaque monkeys, according to a new study. The researchers from the California National Primate Research ...
Oct 13, 2022
0
101
As the world has witnessed firsthand, SARS-CoV-2, the virus that causes COVID, is difficult to control because of its ability to rapidly mutate and produce many different variants. Scientists at Scripps Research have now ...
Aug 10, 2022
0
151
Scientists have reported good news on the pandemic preparedness front: A cocktail of four manufactured antibodies is effective at neutralizing a virus from the Henipavirus family, a group of pathogens considered to be a global ...
Jun 13, 2022
0
111
Globally, breakthrough COVID-19 infections among vaccinated people are increasing, raising concerns about the durability of protection against emerging, highly contagious variants of concern. A study publishing May 5th in ...
May 5, 2022
0
152
People make countless choices every day. It may be a difficult, complex choice—whether to take the job in a new city or stay in a current position—or be as simple as choosing between visiting a new restaurant or going ...
Apr 20, 2022
0
62
When Hurricane Maria slammed into Puerto Rico in September 2017 as a high-end category 4 storm, it left in its wake the largest catastrophe in the history of the island. The storm killed over 3,000 people in its immediate ...
Feb 7, 2022
0
32
A team of researchers at the Chinese Academy of Medical Science has found that a fatty molecule they created worked effectively against a monkey version of HIV. In their paper published in the journal Cell, the group describes ...
An experimental HIV vaccine based on mRNA—the same platform technology used in two highly effective COVID-19 vaccines—shows promise in mice and non-human primates, according to scientists at the National Institute of ...
Dec 9, 2021
0
129
A booster dose of the mRNA-1273 COVID-19 vaccine given to rhesus macaques about six months after their primary vaccine series significantly increased levels of neutralizing antibodies against all known SARS-CoV-2 variants ...
Oct 21, 2021
0
166
A multidisciplinary team of researchers is the first to show combining yeast-expression technology and a novel adjuvant formulation to produce a COVID-19 vaccine candidate is effective against SARS-COV-2 and promises to be ...
Jul 15, 2021
0
14
